FDA approves new drugs
· On Nov. 16, the U.S. Food and Drug Administration (FDA) granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
